LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: How should we define cure after parathyroidectomy for normocalcemic primary hyperparathyroidism? A retrospective cohort study.

    Cano-Valderrama, Oscar / Ochagavía, Santiago / Sanabria, Concepción / Familiar, Cristina / Díaz, Jesús / Picazo, Sara / Sáez-Carlin, Patricia / Torres, Antonio J

    Updates in surgery

    2021  Volume 73, Issue 6, Page(s) 2293–2299

    Abstract: Cure after surgery for normocalcemic primary hyperparathyroidism (NHPT) is defined as parathyroid hormone (PTH) normalization. However, an increase of PTH is frequently observed in cured patients with hypercalcemic primary hyperparathyroidism (HHPT). ... ...

    Abstract Cure after surgery for normocalcemic primary hyperparathyroidism (NHPT) is defined as parathyroid hormone (PTH) normalization. However, an increase of PTH is frequently observed in cured patients with hypercalcemic primary hyperparathyroidism (HHPT). Therefore, this criterion must be redefined. A single-center retrospective study was performed including all patients who underwent surgery for Primary Hyperparathyroidism from 2013 to 2019. Cure rates of different types of hyperparathyroidism were analyzed. PTH reduction was studied as a possible criterion to define cure in patients with NHPT. One-hundred and eighty-six patients were included: 173 with HHPT and 13 with NHPT. After a mean follow-up of 33.4 months, 174 (93.6%) patients were considered cured. Cure was more frequent in the group of patients with HHPT (97.1% vs. 46.2%, p < 0.001). In the multivariate analysis, surgical failure was associated with NHPT and multiglandular disease. Forty-nine (30.1%) cured patients with HHPT had an increased PTH during the follow-up. When decline of PTH levels was studied in patients with HHPT to define cure, the area under curve was 0.92. A cut-off value of 40% in PTH reduction achieved a sensitivity and specificity of 83.4% and 80.0%. If cure was defined as a 40% reduction of PTH, cure rate in the group of patients with NHPT would increase to 69.2%. Patients with NHPT had a lower cure rate than patients with HHPT. A significant number of cured patients with HHPT had an increased PTH during follow-up. A 40% reduction in PTH levels is proposed as an alternative definition for cure in patients with NHPT.
    MeSH term(s) Calcium ; Humans ; Hyperparathyroidism, Primary/surgery ; Parathyroid Hormone ; Parathyroidectomy ; Retrospective Studies
    Chemical Substances Parathyroid Hormone ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2021-06-07
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2572692-4
    ISSN 2038-3312 ; 2038-131X
    ISSN (online) 2038-3312
    ISSN 2038-131X
    DOI 10.1007/s13304-021-01108-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Laparoscopic adrenalectomy vs. radiofrequency ablation for the treatment of primary aldosteronism. A single center retrospective cohort analysis adjusted with propensity score.

    Cano-Valderrama, Oscar / González-Nieto, Jimena / Abad-Cardiel, María / Ochagavía, Santiago / Rünkle, Isabelle / Méndez, José V / García-Donaire, José A / Cuesta-Hernández, Martín / Armijo, Javier E / Miguel-Novoa, Paz / Torres, Antonio J / Martell-Claros, Nieves

    Surgical endoscopy

    2021  Volume 36, Issue 3, Page(s) 1970–1978

    Abstract: Background: Laparoscopic adrenalectomy (LA) is the gold standard treatment for unilateral primary aldosteronism. However, satisfactory results have also been published with radiofrequency ablation (RFA). The aim of this study was to compare LA and RFA ... ...

    Abstract Background: Laparoscopic adrenalectomy (LA) is the gold standard treatment for unilateral primary aldosteronism. However, satisfactory results have also been published with radiofrequency ablation (RFA). The aim of this study was to compare LA and RFA for the treatment of primary aldosteronism.
    Methods: A retrospective cohort study of the patients who underwent LA or RFA in a single center was performed. Morbidity and long-term effectiveness (cure rate and blood pressure control) were analyzed. A multivariate analysis with a propensity score was also performed.
    Results: Thirty-four patients were included in the study, 24 in the LA group and 10 in the RFA group. Hypertension had been diagnosed a median of 12 years before the intervention. Hypertension was properly controlled before the intervention in 55.9% of the patients. Hypertensive crisis was more common during RFA (4.2% vs. 70.0%, p < 0.001), although no patient suffered any complication because of these crises. LA was longer (174.6 vs. 105.5 min, p = 0.001) and had a longer length of stay (median 2 vs 1 days, p < 0.001). No severe complications were observed in any of the patients. After a median follow-up of 46.2 months, more patients had hypertension cured and blood pressure controlled in the LA group (29.2% vs. 0%, p = 0.078 and 95.5% vs. 50.0%, p = 0.006, respectively). Also, patients in the LA group were taking less antihypertensive drugs (1.8 vs. 3.0, p = 0.054) or mineralocorticoid receptor antagonists (41.7% vs. 90.0%, p = 0.020). Multivariate analysis adjusted by propensity score showed that LA had an OR = 11.3 (p = 0.138) for hypertension cure and an OR = 55.1 (p = 0.040) for blood pressure control.
    Conclusions: Although RFA was a less invasive procedure than LA, hypertension was cured and blood pressure was properly controlled in more patients from the LA group. Patients who underwent LA were taking less antihypertensive drugs than patients who had undergone RFA.
    MeSH term(s) Adrenalectomy/methods ; Cohort Studies ; Humans ; Hyperaldosteronism/surgery ; Laparoscopy/methods ; Propensity Score ; Radiofrequency Ablation ; Retrospective Studies ; Treatment Outcome
    Language English
    Publishing date 2021-04-12
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 639039-0
    ISSN 1432-2218 ; 0930-2794
    ISSN (online) 1432-2218
    ISSN 0930-2794
    DOI 10.1007/s00464-021-08481-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Tomografía por emisión de positrones marcada con 18-Fluor-dihidroxifenilalanina para el diagnóstico de feocromocitoma.

    Ramós-Leví, Ana María / Molino, Angel / Ochagavía, Santiago / Díaz Pérez, Angel

    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion

    2013  Volume 60, Issue 6, Page(s) 336–338

    Title translation 6-[F18]-fluoro-dihydroxyphenylalanine positron emission tomography for diagnosis of pheochromocytoma.
    MeSH term(s) Adrenal Gland Neoplasms/diagnostic imaging ; Adult ; Dihydroxyphenylalanine/analogs & derivatives ; Female ; Fluorine Radioisotopes ; Humans ; Pheochromocytoma/diagnostic imaging ; Positron-Emission Tomography/methods
    Chemical Substances Fluorine Radioisotopes ; fluorodopa F 18 (2C598205QX) ; Dihydroxyphenylalanine (63-84-3)
    Language Spanish
    Publishing date 2013-06
    Publishing country Spain
    Document type Case Reports ; Letter
    ZDB-ID 1469349-5
    ISSN 1579-2021 ; 0211-2299 ; 1575-0922
    ISSN (online) 1579-2021
    ISSN 0211-2299 ; 1575-0922
    DOI 10.1016/j.endonu.2012.06.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top